Description

LL-37, human TFA is a 37-residue, amphipathic, cathelicidin-derived antimicrobial peptide, which exhibits a broad spectrum of antimicrobial activity. LL-37, human TFA could help protect the cornea from infection and modulates wound healing[1][2][3].–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)–COVID-19-immunoregulation–C205H340N60O53.xC2HF3O2—Int Immunopharmacol. 2024 Feb 15:129:111636.|Commun Biol. 2022 Jun 8;5(1):559.-[1]Dürr UH, et al. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta. 2006 Sep;1758(9):1408-25.|[2]Huang LC, et al. Multifunctional roles of human cathelicidin (LL-37) at the ocular surface. Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2369-80.|[3]Hou M, et al. Antimicrobial peptide LL-37 and IDR-1 ameliorate MRSA pneumonia in vivo. Cell Physiol Biochem. 2013;32(3):614-23.—-4493.26 (free base)–99.71–[LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES (TFA salt)]–Infection–H2O : 100 mg/mL (ultrasonic)–Bacterial—-Anti-infection–Peptides